The GHP Oral Antihypertensive Trial aims to compare the efficacy of oral labetalol, oral nifedipine, and oral methyldopa for the management of severe hypertension in pregnant women. The study is enrolling at two sites in Nagpur, India: Government Medical College (GMC) and Daga Women’s Hospital.
Graph: Enrollment of women in the GHP trial as of April 30, 2016.
The study has enrolled 341 women as of April 30, 2016. Gynuity Health Projects conducted a monitoring visit at GMC Nagpur and Daga Memorial Hospital on March 7-8, 2016. Congratulations to the sites for their hard work!